Grants paid by Pancreatic Cancer Cure Foundation
EIN 81-5164082 · Quakertown, PA · Form 990, Schedule I · NTEE H11
Pancreatic Cancer Cure Foundation of Quakertown, PA (EIN 81-5164082) reported 14 grants paid totaling $366,882 to 3 recipients in tax years 2018–2024, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$366,882
14 grants
Recipients
3
distinct organizations
Tax years
2018–2024
7 filings in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2018 | 1 | $15,157 | — |
| 2019 | 2 | $63,943 | — |
| 2020 | 2 | $33,000 | — |
| 2021 | 3 | $70,000 | — |
| 2022 | 2 | $59,782 | — |
| 2023 | 2 | $66,000 | — |
| 2024 | 2 | $59,000 | — |
Top recipients
The 3 recipients receiving the most from Pancreatic Cancer Cure Foundation, by grants paid, out of 3 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Thomas Jefferson University 23-1352651 | A | Philadelphia, PA | 7 | $239,382 | 2024 |
| Fox Chase Institute for Cancer Research 23-6296135 | A | Philadelphia, PA | 4 | $105,500 | 2024 |
| St Luke's Hospital of Bethlehem 23-1352213 | A | Bethlehem, PA | 3 | $22,000 | 2021 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 14 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | Thomas Jefferson University Philadelphia, PA | A | $32,000 | paid | $30,000 IN FUNDING WAS PROVIDED TO THE PANCREAS, BILIARY, & RELATED CANCER CENTER AT SIDNEY KIMMEL CANCER CENTER AT JEFFERSON UNIVERSITY, AN NCI-DESIGNATED FACILITY. FUNDING SUPPORTS RESEARCH TO IMPROVE EARLY DETECTION OF PANCREATIC CANCER AND DEVELOP MORE EFFECTIVE SCREENING PROCEDURES. THIS FACILITY IS LEADING INVESTIGATIONS INTO GENETIC, ENVIRONMENTAL, AND LIFESTYLE LINKS TO PANCREATIC AND RELATED CANCERS, INCLUDING NOVEL APPROACHES TO INDIVIDUALIZED THERAPY BASED ON MOLECULAR GENETIC FEATURES OF TUMORS. $2,000 IN FUNDING WAS USED FOR JEFFERSON'S "COMPASSIONATE CARE" INITIATIVES. | 202530459349300238 |
| 2024 | Fox Chase Institute for Cancer Research Philadelphia, PA | A | $27,000 | paid | FUNDING WAS PROVIDED TO FOX CHASE INSTITUTE FOR CANCER RESEARCH TO ADVANCE RESEARCH BEING CONDUCTED BY THE CUIKERMAN LAB/MARVIN & CONCETTA GREENBURG PANCREATIC CANCER INSTITUTE | 202530459349300238 |
| 2023 | Thomas Jefferson University Philadelphia, PA | A | $36,000 | paid | FUNDING PROVIDED TO THE PANCREAS, BILIARY, & RELATED CANCER CENTER AT SIDNEY KIMMEL CANCER CENTER AT JEFFERSON UNIVERSITY, AN NCI-DESIGNATED FACILITY. FUNDING SUPPORTS RESEARCH TO IMPROVE EARLY DETECTION OF PANCREATIC CANCER AND DEVELOP MORE EFFECTIVE SCREENING PROCEDURES. THIS FACILITY IS LEADING INVESTIGATIONS INTO GENETIC, ENVIRONMENTAL, AND LIFESTYLE LINKS TO PANCREATIC AND RELATED CANCERS, INCLUDING NOVEL APPROACHES TO INDIVIDUALIZED THERAPY BASED ON MOLECULAR GENETIC FEATURES OF TUMORS. | 202432269349301058 |
| 2023 | Fox Chase Institute for Cancer Research Philadelphia, PA | A | $30,000 | paid | FUNDING WAS PROVIDED TO FOX CHASE INSTITUTE FOR CANCER RESEARCH TO ADVANCE RESEARCH BEING CONDUCTED BY THE CUIKERMAN LAB/MARVIN & CONCETTA GREENBURG PANCREATIC CANCER INSTITUTE | 202432269349301058 |
| 2022 | Thomas Jefferson University Philadelphia, PA | A | $39,782 | paid | FUNDING PROVIDED TO THE PANCREAS, BILIARY, & RELATED CANCER CENTER AT SIDNEY KIMMEL CANCER CENTER AT JEFFERSON UNIVERSITY, AN NCI-DESIGNATED FACILITY. FUNDING SUPPORTS RESEARCH TO IMPROVE EARLY DETECTION OF PANCREATIC CANCER AND DEVELOP MORE EFFECTIVE SCREENING PROCEDURES. THIS FACILITY IS LEADING INVESTIGATIONS INTO GENETIC, ENVIRONMENTAL, AND LIFESTYLE LINKS TO PANCREATIC AND RELATED CANCERS, INCLUDING NOVEL APPROACHES TO INDIVIDUALIZED THERAPY BASED ON MOLECULAR GENETIC FEATURES OF TUMORS. | 202322279349300407 |
| 2022 | Fox Chase Institute for Cancer Research Philadelphia, PA | A | $20,000 | paid | FUNDING WAS PROVIDED TO FOX CHASE INSTITUTE FOR CANCER RESEARCH TO ADVANCE RESEARCH BEING CONDUCTED BY THE CUIKERMAN LAB/MARVIN & CONCETTA GREENBURG PANCREATIC CANCER INSTITUTE | 202322279349300407 |
| 2021 | Thomas Jefferson University Philadelphia, PA | A | $36,500 | paid | FUNDING PROVIDED TO THE PANCREAS, BILIARY, & RELATED CANCER CENTER AT SIDNEY KIMMEL CANCER CENTER AT JEFFERSON UNIVERSITY, AN NCI-DESIGNATED FACILITY. FUNDING SUPPORTS RESEARCH TO IMPROVE EARLY DETECTION OF PANCREATIC CANCER AND DEVELOP MORE EFFECTIVE SCREENING PROCEDURES. THIS FACILITY IS LEADING INVESTIGATIONS INTO GENETIC, ENVIRONMENTAL, AND LIFESTYLE LINKS TO PANCREATIC AND RELATED CANCERS, INCLUDING NOVEL APPROACHES TO INDIVIDUALIZED THERAPY BASED ON MOLECULAR GENETIC FEATURES OF TUMORS. | 202212279349301416 |
| 2021 | Fox Chase Institute for Cancer Research Philadelphia, PA | A | $28,500 | paid | FUNDING WAS PROVIDED TO FOX CHASE INSTITUTE FOR CANCER RESEARCH TO ADVANCE RESEARCH BEING CONDUCTED BY THE CUIKERMAN LAB/MARVIN & CONCETTA GREENBURG PANCREATIC CANCER INSTITUTE | 202212279349301416 |
| 2021 | St Luke's Hospital of Bethlehem Bethlehem, PA | A | $5,000 | paid | FUNDING WAS PROVIDED TO ST. LUKE'S CANCER CENTER FOR "COMPASSIONATE CARE" DISTRIBUTION TO FINANCIALLY COMPROMISED PANCREATIC CANCER PATIENTS TO COVER COSTS SUCH AS TRANSPORTATION, UTILITIES, ETC. | 202212279349301416 |
| 2020 | Thomas Jefferson University Philadelphia, PA | A | $29,000 | paid | FUNDING PROVIDED TO THE PANCREAS, BILIARY, & RELATED CANCER CENTER AT SIDNEY KIMMEL CANCER CENTER AT JEFFERSON UNIVERSITY, AN NCI-DESIGNATED FACILITY. FUNDING SUPPORTS RESEARCH TO IMPROVE EARLY DETECTION OF PANCREATIC CANCER AND DEVELOP MORE EFFECTIVE SCREENING PROCEDURES. THIS FACILITY IS LEADING INVESTIGATIONS INTO GENETIC, ENVIRONMENTAL, AND LIFESTYLE LINKS TO PANCREATIC AND RELATED CANCERS, INCLUDING NOVEL APPROACHES TO INDIVIDUALIZED THERAPY BASED ON MOLECULAR GENETIC FEATURES OF TUMORS. | 202102239349301985 |
| 2020 | St Luke's Hospital of Bethlehem Bethlehem, PA | A | $4,000 | paid | FUNDING WAS PROVIDED TO ST. LUKE'S CANCER CENTER FOR "COMPASSIONATE CARE" DISTRIBUTION TO FINANCIALLY COMPROMISED PANCREATIC CANCER PATIENTS TO COVER COSTS SUCH AS TRANSPORTATION, UTILITIES, ETC. | 202102239349301985 |
| 2019 | Thomas Jefferson University Philadelphia, PA | A | $50,943 | paid | FUNDING WAS ALLOCATED TO GENERAL FUNDING OF THE JEFFERSON PANCREAS, BILLIARY AND RELATED CANCER CENTER (BRODY LAB) WHICH IS PRESENTLY FOCUSED ON HUR BIOLOGY WITH REGARD TO PANCREATIC CANCER TUMORIGENESIS AND CANCER CELL SURVIVAL ALONG WITH CONTINUING RESEARCH IN DRUG-TARGET RELATIONSHIPS LEADING TO MOLECULAR BASED PERSONALIZED APPROACH TO TREATING PANCREATIC CANCER. | 202012269349300311 |
| 2019 | St Luke's Hospital of Bethlehem Bethlehem, PA | A | $13,000 | paid | FUNDING WAS PROVIDED FOR START-UP MONEY FOR A NEW PROGRAM WITHIN THE ST. LUKE'S HEALTH NETWORK WHICH WILL PROVIDE DIRECT SUPPORT (TRANSPORTATION, UTILITIES, ETC.) FOR PANCREATIC CANCER PATIENTS WHO ARE FINANCIALLY COMPROMISED. | 202012269349300311 |
| 2018 | Thomas Jefferson University Philadelphia, PA | A | $15,157 | paid | $10,000 OF THIS AMOUNT WAS SPECIFICALLY ALLOCATED TO SEED A CLINICAL TRIAL BY COVERING THE INITIAL MEDICATION COSTS. THE CLINICAL TRIAL WAS DESIGNED TO STUDY THE RELATIONSHIP BETWEEN DEPRESSION AND PANCREATIC CANCER AND BY EXPLORING THIS RELATIONSHIP, SEEK TO UNDERSTAND WHETHER DEPRESSION MIGHT BE A SYMPTOM OF PANCREATIC CANCER WHICH COULD POTENTIALLY ASSIST IN EARLY DETECTION, AND/OR UNDERSTAND THE EFFECTS DEPRESSION MANAGEMENT MAY HAVE ON PATIENT TREATMENT AND OUTCOMES. THE BALANCE WAS ALLOCATED TO GENERAL FUNDING OF THE JEFFERSON PANCREAS, BILLIARY AND RELATED CANCER CENTER (BRODY LAB) WHICH IS PRESENTLY FOCUSED ON HUR BIOLOGY WITH REGARD TO PANCREATIC CANCER TUMORIGENESIS AND CANCER CELL SURVIVAL ALONG WITH CONTINUING RESEARCH IN DRUG-TARGET RELATIONSHIPS LEADING TO MOLECULAR BASED PERSONALIZED APPROACH TO TREATING PANCREATIC CANCER. | 201912249349300901 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990 | 2024 | 2024-09-30 | not stated | 2023v6.0 | 202530459349300238 |
| 990 | 2023 | 2023-09-30 | not stated | 2022v5.0 | 202432269349301058 |
| 990 | 2022 | 2022-09-30 | not stated | 2021v4.2 | 202322279349300407 |
| 990 | 2021 | 2021-09-30 | not stated | 2020v4.2 | 202212279349301416 |
| 990 | 2020 | 2020-09-30 | not stated | 2019v5.2 | 202102239349301985 |
| 990 | 2019 | 2019-09-30 | not stated | 2018v3.2 | 202012269349300311 |
| 990 | 2018 | 2018-09-30 | not stated | 2017v2.3 | 201912249349300901 |
Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/815164082.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.